Industry

New white paper outlines trauma-informed teaching strategies that support student well-being, faculty wellness and course completion for working adult learners PHOENIX–(BUSINESS WIRE)–University of Phoenix College of Social and Behavioral Sciences announces a new white paper, “Trauma-Informed Education – A Pathway for Relief, Retention, and Renewal,” authored by College leadership Sheila Babendir, Ed.D., LPAC; Barbara Burt, … [Read more…]

– Vimseltinib demonstrated statistically significant and clinically meaningful benefit vs placebo in antitumor response – OSAKA, Japan & WALTHAM, Mass.–(BUSINESS WIRE)–Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the two-year efficacy and safety results from its MOTION Phase 3 study of vimseltinib in patients with TGCT in cases … [Read more…]

5 confirmed partial responses (PRs) among 13 evaluable non-small cell lung cancer (NSCLC) patients (ORR 38%); 1 confirmed PR among 7 breast cancer patients Favorable safety and PK profile, with encouraging activity, demonstrate a therapeutic window for JK06 Company proceeding with expansion cohorts in NSCLC and breast cancer GAITHERSBURG, Md.–(BUSINESS WIRE)–Salubris Biotherapeutics, Inc. (SalubrisBio), a … [Read more…]

WINTER PARK, Fla.–(BUSINESS WIRE)–Humata Health today announced plans to make its AI-powered prior authorization technology available with Microsoft Dragon Copilot. By delivering enhanced capabilities within this ambient-powered AI clinical assistant, Humata Health will enable clinicians to automate and streamline crucial prior authorization tasks, ultimately reducing provider burden and accelerating patient access to appropriate care. Humata … [Read more…]

BOCA RATON, Fla.–(BUSINESS WIRE)–During the ongoing government shutdown, ClinicalTrials.gov, the nation’s central registry for medical research and clinical studies, has gone offline, leaving millions of patients with cancer and other serious diseases unable to search for potentially life-saving clinical trials. “This should alarm every American,” said Dr. Arturo Loaiza-Bonilla, Co-Founder and Chief Medical & AI … [Read more…]

Wnt/β-catenin pathway, first identified as a key cancer driver over 30 years ago and implicated in millions of cancer cases annually, is not addressed by any currently approved therapies Oral presentation at ESMO 2025 shows FOG-001 – Parabilis’s lead investigational Helicon™ peptide, targeting the β-catenin:TCF interaction – demonstrated tumor reductions in 100% of desmoid patients … [Read more…]

HARMONi-GI3 is the Fourth Global Phase III Study of Ivonescimab and First Global Study beyond NSCLC Clinical Trial Site Activations Planned to Begin This Quarter in the United States Conference Call to be Held at 8:00am ET on Monday, October 20, 2025 MIAMI–(BUSINESS WIRE)–$SMMT–Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) today announced … [Read more…]

The National Measurement Laboratory, Government Chemist and MHRA – three critical national functions of science and safety – brought together in a purpose-designed laboratory facility for the first time GUILDFORD, England–(BUSINESS WIRE)–LGC Group, a global leader in life sciences, diagnostics, and analytical solutions, today officially opened its new state-of-the-art National Laboratories facility in Guildford. This … [Read more…]

One of just nine voucher recipients chosen and the only one in the eye space, the selection spotlights Dompé’s dedication to accelerate innovation and deliver breakthrough therapies to patients who urgently need them. With this selection, Dompé receives a voucher shortening the marketing application review from the standard 10–12 months to just 1–2 months. Dompé … [Read more…]

The Deeply Personal Documentary Follows Chris and His Father on a Road Trip Back in Time as They Explore the Scientific Impacts Behind Social Connection and Reminiscence Therapy as Methods To Stimulate Mental Activity, Evoke Memories and Improve Well-being — Hopeful Tools in the Fight Against Memory Loss and Cognitive Decline CHRIS HEMSWORTH: A ROADTRIP … [Read more…]